Life Sciences Quality Management Software Market Size Projected to Reach $11.40 billion by 2034 | 12.78%

According to Straits Research, the global life sciences quality management software market size was valued at $3.87 billion in 2025 and is projected to reach $11.40 billion by 2034, growing at a CAGR of 12.78% during the forecast period 2026–2034.

Market Dynamics

A key driver for the life sciences quality management software market is the growing adoption of unified digital platforms that streamline documentation, deviations, audits, and training activities across regulated pharmaceutical, biotechnology, and contract manufacturing environments. Organizations are prioritizing structured quality workflows to meet evolving regulatory expectations and support consistent oversight across global operations. However, a restraint stems from the slow migration away from paper-based archives and lengthy validation cycles in older facilities, which delays system rollout and limits rapid implementation in firms with established manual processes. An emerging opportunity lies in the expansion of remote quality-review and virtual audit programs, which allow teams to conduct oversight activities without frequent onsite inspections. These digital models improve accessibility for distributed facilities and create wider pathways for software adoption across international quality networks.

Market Segments

1. By Application (2026-2034)
   1. Data Management
   2. Training Management
   3. Supplier Management
   4. Regulatory and Compliance Management
   5. Corrective Action and Preventive Action (CAPA) Management
   6. Audit Management
   7. Change Management
   8. Non-conformances Management
   9. Inspection Management
   10. Risk Management
   11. Others
2. By Deployment Mode (2026-2034)
   1. Cloud & Web-based
   2. On-premises
3. By End Use (2026-2034)
   1. Pharmaceutical Firms
   2. Biotech Firms
   3. CROs/CDMOs